Details
Stereochemistry | ACHIRAL |
Molecular Formula | C24H30N4O.C4H4O4 |
Molecular Weight | 506.5934 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 1 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
OC(=O)\C=C\C(O)=O.CCN(CC)CCCNC(=O)CN1N=CC(=C1C2=CC=CC=C2)C3=CC=CC=C3
InChI
InChIKey=KKMOBFCMCCFTDX-WLHGVMLRSA-N
InChI=1S/C24H30N4O.C4H4O4/c1-3-27(4-2)17-11-16-25-23(29)19-28-24(21-14-9-6-10-15-21)22(18-26-28)20-12-7-5-8-13-20;5-3(6)1-2-4(7)8/h5-10,12-15,18H,3-4,11,16-17,19H2,1-2H3,(H,25,29);1-2H,(H,5,6)(H,7,8)/b;2-1+
Ipazilide is an antiarrhythmic agent that prolongs ventricular refractoriness and possesses antiectopic activity. In clinical trials ipazilide administrations leads to dose- and time-dependent in decrease cardiac index and arterial pressure. Left ventricular filling pressure, right atrial pressure, and heart rate were not altered by ipazilide. Plasma concentrations of ipazilide peaked 90 minutes after administration of 100 or 200 of the drug, but peak concentrations were noted 3 hours after administration of 400 mg. The hemodynamic response correlated with the plasma concentration of ipazilide determined contemporaneously.
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: Potassium channel Sources: https://adisinsight.springer.com/drugs/800001765 |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/8033497
400, 200, and 100 mg single-dose
Route of Administration:
Oral
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C47793
Created by
admin on Fri Dec 15 15:59:06 GMT 2023 , Edited by admin on Fri Dec 15 15:59:06 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
C076683
Created by
admin on Fri Dec 15 15:59:06 GMT 2023 , Edited by admin on Fri Dec 15 15:59:06 GMT 2023
|
PRIMARY | |||
|
2MI60P494I
Created by
admin on Fri Dec 15 15:59:06 GMT 2023 , Edited by admin on Fri Dec 15 15:59:06 GMT 2023
|
PRIMARY | |||
|
5284403
Created by
admin on Fri Dec 15 15:59:06 GMT 2023 , Edited by admin on Fri Dec 15 15:59:06 GMT 2023
|
PRIMARY | |||
|
CHEMBL2111169
Created by
admin on Fri Dec 15 15:59:06 GMT 2023 , Edited by admin on Fri Dec 15 15:59:06 GMT 2023
|
PRIMARY | |||
|
C81425
Created by
admin on Fri Dec 15 15:59:06 GMT 2023 , Edited by admin on Fri Dec 15 15:59:06 GMT 2023
|
PRIMARY | |||
|
115436-74-3
Created by
admin on Fri Dec 15 15:59:06 GMT 2023 , Edited by admin on Fri Dec 15 15:59:06 GMT 2023
|
PRIMARY | |||
|
AA-112
Created by
admin on Fri Dec 15 15:59:06 GMT 2023 , Edited by admin on Fri Dec 15 15:59:06 GMT 2023
|
PRIMARY | |||
|
DTXSID9020744
Created by
admin on Fri Dec 15 15:59:06 GMT 2023 , Edited by admin on Fri Dec 15 15:59:06 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
PARENT (SALT/SOLVATE)
SUBSTANCE RECORD